Jazz Pharmaceuticals plc (J7Z) - Total Liabilities

Latest as of March 2026: €7.33 Billion EUR ≈ $8.57 Billion USD

Based on the latest financial reports, Jazz Pharmaceuticals plc (J7Z) has total liabilities worth €7.33 Billion EUR (≈ $8.57 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore J7Z long-term investments to assets to see how much of total assets are deployed in long-term investments.

Jazz Pharmaceuticals plc - Total Liabilities Trend (2013–2025)

This chart illustrates how Jazz Pharmaceuticals plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Jazz Pharmaceuticals plc.

Jazz Pharmaceuticals plc Competitors by Total Liabilities

The table below lists competitors of Jazz Pharmaceuticals plc ranked by their total liabilities.

Company	Country	Total Liabilities
Doosan Corp. KO:000150	Korea	₩21.45 Trillion
ZTO Express (Cayman) Inc F:ZTOA	Germany	€25.18 Billion
Xiamen Tungsten Co Ltd SHG:600549	China	CN¥35.56 Billion
Henan Shuanghui Investment & Development Co Ltd SHE:000895	China	CN¥20.67 Billion
Nanya New Material Technology Co Ltd SHG:688519	China	CN¥4.65 Billion
Taiwan Mobile Co Ltd TW:3045	Taiwan	NT$145.33 Billion
Dynatrace Holdings LLC NYSE:DT	USA	$1.80 Billion
Muthoot Finance Limited NSE:MUTHOOTFIN	India	Rs1.68 Trillion

Liability Composition Analysis (2013–2025)

This chart breaks down Jazz Pharmaceuticals plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See J7Z net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.62	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jazz Pharmaceuticals plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jazz Pharmaceuticals plc (2013–2025)

The table below shows the annual total liabilities of Jazz Pharmaceuticals plc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€7.34 Billion ≈ $8.58 Billion	-7.30%
2024-12-31	€7.92 Billion ≈ $9.26 Billion	+3.42%
2023-12-31	€7.66 Billion ≈ $8.95 Billion	-1.20%
2022-12-31	€7.75 Billion ≈ $9.06 Billion	-7.01%
2021-12-31	€8.33 Billion ≈ $9.74 Billion	+189.74%
2020-12-31	€2.88 Billion ≈ $3.36 Billion	+18.46%
2019-12-31	€2.43 Billion ≈ $2.84 Billion	-0.74%
2018-12-31	€2.45 Billion ≈ $2.86 Billion	+1.47%
2017-12-31	€2.41 Billion ≈ $2.82 Billion	-17.53%
2016-12-31	€2.92 Billion ≈ $3.42 Billion	+68.57%
2015-12-31	€1.73 Billion ≈ $2.03 Billion	-11.88%
2014-12-31	€1.97 Billion ≈ $2.30 Billion	+108.74%
2013-12-31	€942.69 Million ≈ $1.10 Billion	--

About Jazz Pharmaceuticals plc

F:J7Z Germany Biotechnology

Market Cap

$15.26 Billion

€13.05 Billion EUR

Market Cap Rank

#1960 Global

#412 in Germany

Share Price

€208.00

Change (1 day)

-2.26%

52-Week Range

€108.25 - €225.90

All Time High

€225.90